Pharmaceutical News and Articles
Print Email

Phase Bioscience Announces New Collaboration with Centocor Research and Development

DURHAM, N.C.--(BUSINESS WIRE)--Jan 3, 2008 - Phase Bioscience, Inc., (PhaseBio) a development stage biotechnology company, announced today that Centocor Research and Development Inc. has licensed PhaseBio's patented deltaPhaseTM process for use in its research applications. PhaseBio's deltaPhase technology offers new solutions for the production and purification of protein-based therapeutics, including polypeptides, proteins or antibodies and provides substantial advantages over current biological production methods. The advantages seen with PhaseBio's process include: increased yields, high throughput and elimination of chromatography steps for final product purification. "We are extremely pleased that Centocor has decided to extend their successful collaboration with PhaseBio," stated Clay B. Thorp, Chairman of the Board, Phase Bioscience, Inc.

Under the terms of the agreement, Centocor will have rights to utilize the deltaPhase technology in their research.

About deltaPhaseTM

The deltaPhase recombinant expression/purification system is based on the transition properties of Elastin-Like Peptides (ELPs) and their ability to retain this inverse temperature phase transition when conjugated to other molecules, providing a new method of purification for therapeutic proteins and peptides. deltaPhase offers an innovative method for protein/polypeptide purification, while avoiding costly chromatography. This technology represents the first new method for production and purification of biologics in 20 years.

About Phase Bioscience, Inc.

Phase Biocience, Inc. (PhaseBio), located in Research Triangle Park, NC, is a privately held biopharmaceutical company molded around an innovative set of technologies that provide new solutions to the delivery, production and purification of protein-based therapeutics and small molecule therapeutics. Our proprietary Elastin-Like Peptide (ELP) technology enables the Company and its partners to efficiently express and purify proteins and dramatically improve their pharmaceutical attributes. The Company's deltaPhase process for biologic purification eliminates expensive chromatography.

Contact

Phase Bioscience, Inc.
June Edgerton, 919-544-6177
Office Manager
june.edgerton@phasebio.com

Latest Pharma Industry News...

Pharma Industry News Archive

2009: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov
2008: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2007: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2006: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2005: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2004: Jan | Feb | Mar | Apr | May | Jul | Aug | Sep | Oct | Nov | Dec
2003: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2002: Jan | Apr | May | Jun | Aug | Sep | Oct | Nov | Dec

More News Resources

Daily MedNews
Pharma Industry News
New Drug Applications
New Drug Approvals
Clinical Trial Results
Generic Drug Approvals
Monthly Update Archive

Services
Home
A to Z Drug List
Drugs by Condition
Drug Side Effects
Natural Products
Community Forums
Interactive Tools
Pill Identifier
Interactions Checker
MedNotes beta
Support Groups beta
Drug Image Search
Phonetic Search
News & Articles
Latest Drug News
FDA Drug Alerts
New Drug Approvals
New Drug Applications
Clinical Trial Results
Medical Encyclopedia
News FeedsRSS Feeds
Health Professionals
Professional Resources
Drugs by Classification
Patient Care Notes
Drug Imprint Codes
Medical Dictionary
Animal Medicine
Veterinary Drugs
Advertise Here
Recent Searches
Coricidin
Niaspan
Ammonul
Myfortic
Soliris
Kadian
Fosamax Plus D
Methadone
Percogesic
Zelapar
Menostar
Meclizine
Propecia
Xenical
Potassium
Isosorbide
Ultane
Perlane
Besivance
Integrilin
Prozac
Forteo
Prednisone
Alprazolam
Pylera
Recently Approved
Qutenza
Lysteda
Istodax
Pennsaid
Arzerra
Votrient
Twynsta
Cervarix
Berinert
Stelara
More...

Subscribe to our popular newsletter containing a regular roundup of medication news, alerts and new drug approvals.


MedNotes
Most Popular Internet Searches
Lipitor
Viagra
Zoloft
Crestor
 Cialis
Wellbutrin
Effexor
Celebrex
 Levitra
Neurontin
Paxil
Zocor
Latest FDA Drug Alerts
RSS
Get alerts delivered by email
Meridia (sibutramine hydrochloride): Early Communication about an Ongoing Safety Review
November 20, 2009
FDA notified healthcare professionals and patients that it is reviewing preliminary data from a recent study suggesting that...
Vicks Sinex Nasal Spray - Recall
November 19, 2009
Procter & Gamble and FDA notified consumers of a voluntary recall of three lots of Vicks Sinex Nasal Spray in the United...
RockHard Weekend - product contains undeclared drug ingredient
November 18, 2009
RockHard Laboratories and FDA notified consumers that RockHard Weekend, a product sold as a dietary supplement, contains...
Clopidogrel (marketed as Plavix) and Omeprazole (marketed as Prilosec) - Drug Interaction
November 17, 2009
FDA notified healthcare professionals of new safety information concerning an interaction between clopidogrel (Plavix), an...
More...
Advertisement
Latest Drug Information Updates

Qutenza
Qutenza is a capsaicin transdermal patch for the management of pain due to postherpetic neuralgia.

Lysteda
Lysteda (tranexamic acid) is an antifibrinolytic agent for the treatment of women with menorrhagia, heavy menstrual bleeding (HMB), and its accompanying symptoms.

Pennsaid
Pennsaid is a topical non-steroidal anti-inflammatory drug (NSAID) used for the treatment of signs and symptoms of osteoarthritis of the knee.

Istodax
Istodax (romidepsin) a histone deacetylase (HDAC) inhibitor indicated the treatment of cutaneous T-cell lymphoma.

Cervarix
Cervarix (human papillomavirus bivalent (types 16 and 18) is a is a preventative cervical cancer vaccine for the prevention of cervical pre-cancers and cervical cancer associated with oncogenic human papillomavirus (HPV) types 16 and 18 in girls and young women (aged 10-25).

Votrient
Votrient (pazopanib) is a kinase inhibitor indicated for the treatment of patients with advanced renal cell carcinoma.

Arzerra
Arzerra (ofatumumab) is a CD20-directed cytolytic monoclonal antibody indicated for the treatment of patients with chronic lymphocytic leukemia.

Twynsta
Twynsta (telmisartan/amlodipine) is an angiotensin II receptor blocker (ARB) and a dihydropyridine calcium channel blocker (DHP-CCB) combination product indicated for the treatment of hypertension alone or with other antihypertensive agents.

Berinert
Berinert (C1-esterase inhibitor (human)) is a plasma derived C1 Esterase Inhibitor indicated for the treatment of acute abdominal or facial attacks of hereditary angioedema (HAE) in adult and adolescent patients.

Stelara
Stelara (ustekinumab) is a human monoclonal antibody for the treatment of moderate to severe plaque psoriasis.

Influenza A (H1N1) 2009 Monovalent Vaccine
Influenza A (H1N1) 2009 Monovalent Vaccine is an inactivated influenza virus vaccine indicated for active immunization of persons ages 18 years of age and older against influenza disease caused by pandemic (H1N1) 2009 virus.

Zirgan
Zirgan (ganciclovir ophthalmic gel) is a topical ophthalmic antiviral preparation for the treatment of acute herpetic keratitis (dendritic ulcers).

Vibativ
Vibativ (telavancin) is a bactericidal, once-daily injectable antibiotic for the treatment of complicated skin and skin structure infections (cSSSI) caused by susceptible Gram-positive bacteria, including Staphylococcus aureus, both methicillin-resistant (MRSA) and methicillin-susceptible (MSSA) strains.

Folotyn
Folotyn (pralatrexate) is a folate analogue metabolic inhibitor indicated for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma (PTCL).

Valturna
Valturna is a combination of aliskiren (a direct renin inhibitor) and valsartan (an angiotensin II receptor blocker) indicated for the treatment of high blood pressure.

More...

(web4)